258 related articles for article (PubMed ID: 11574678)
1. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs.
Sazani P; Kang SH; Maier MA; Wei C; Dillman J; Summerton J; Manoharan M; Kole R
Nucleic Acids Res; 2001 Oct; 29(19):3965-74. PubMed ID: 11574678
[TBL] [Abstract][Full Text] [Related]
2. Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotides.
Sazani P; Astriab-Fischer A; Kole R
Antisense Nucleic Acid Drug Dev; 2003; 13(3):119-28. PubMed ID: 12954112
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
Schmajuk G; Sierakowska H; Kole R
J Biol Chem; 1999 Jul; 274(31):21783-9. PubMed ID: 10419493
[TBL] [Abstract][Full Text] [Related]
4. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues.
Sazani P; Gemignani F; Kang SH; Maier MA; Manoharan M; Persmark M; Bortner D; Kole R
Nat Biotechnol; 2002 Dec; 20(12):1228-33. PubMed ID: 12426578
[TBL] [Abstract][Full Text] [Related]
5. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain.
Karras JG; Maier MA; Lu T; Watt A; Manoharan M
Biochemistry; 2001 Jul; 40(26):7853-9. PubMed ID: 11425312
[TBL] [Abstract][Full Text] [Related]
6. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
Dominski Z; Kole R
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8673-7. PubMed ID: 8378346
[TBL] [Abstract][Full Text] [Related]
7. Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.
Shiraishi T; Nielsen PE
Artif DNA PNA XNA; 2011; 2(3):90-9. PubMed ID: 22567192
[TBL] [Abstract][Full Text] [Related]
8. Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells.
Shiraishi T; Hamzavi R; Nielsen PE
Nucleic Acids Res; 2008 Aug; 36(13):4424-32. PubMed ID: 18596083
[TBL] [Abstract][Full Text] [Related]
9. Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers.
Ghosh C; Iversen PL
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):263-74. PubMed ID: 10984120
[TBL] [Abstract][Full Text] [Related]
10. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
Resina S; Abes S; Turner JJ; Prevot P; Travo A; Clair P; Gait MJ; Thierry AR; Lebleu B
Int J Pharm; 2007 Nov; 344(1-2):96-102. PubMed ID: 17600642
[TBL] [Abstract][Full Text] [Related]
11. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ
Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483
[TBL] [Abstract][Full Text] [Related]
12. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
Liu Y; Franzen S
Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455
[TBL] [Abstract][Full Text] [Related]
13. Five-step process for screening antisense compounds for efficacy: gene target IL-12Rb2.
Marshall NB; Hauck LL; Mourich DV
Methods Mol Biol; 2011; 764():153-68. PubMed ID: 21748639
[TBL] [Abstract][Full Text] [Related]
14. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.
Sierakowska H; Sambade MJ; Agrawal S; Kole R
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12840-4. PubMed ID: 8917506
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.
Kang H; Fisher MH; Xu D; Miyamoto YJ; Marchand A; Van Aerschot A; Herdewijn P; Juliano RL
Nucleic Acids Res; 2004; 32(14):4411-9. PubMed ID: 15316104
[TBL] [Abstract][Full Text] [Related]
16. Effective delivery of antisense peptide nucleic acid oligomers into cells by anthrax protective antigen.
Wright DG; Zhang Y; Murphy JR
Biochem Biophys Res Commun; 2008 Nov; 376(1):200-5. PubMed ID: 18774771
[TBL] [Abstract][Full Text] [Related]
17. Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.
Yoo H; Juliano RL
Nucleic Acids Res; 2000 Nov; 28(21):4225-31. PubMed ID: 11058121
[TBL] [Abstract][Full Text] [Related]
18. The high binding affinity of phosphorothioate-modified oligomers for Ff gene 5 protein is moderated by the addition of C-5 propyne or 2'-O-methyl modifications.
Mou TC; Gray DM
Nucleic Acids Res; 2002 Feb; 30(3):749-58. PubMed ID: 11809888
[TBL] [Abstract][Full Text] [Related]
19. Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides.
Suwanmanee T; Sierakowska H; Lacerra G; Svasti S; Kirby S; Walsh CE; Fucharoen S; Kole R
Mol Pharmacol; 2002 Sep; 62(3):545-53. PubMed ID: 12181431
[TBL] [Abstract][Full Text] [Related]
20. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
